First Trust Advisors LP purchased a new position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exch
Average weekly trading volume of approximately 657,930 shares
Mesa Laboratories (NASDAQ:MLAB) was upgraded by BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Wednesday, BidAskClub reports. Several other e
Mesa Laboratories, Inc. (NASDAQ:MLAB) SVP Brian David Archbold sold 123 shares of the company’s stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average pric
Comerica Bank trimmed its position in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 1.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The
Mesa Laboratories, Inc. (NASDAQ:MLAB) reached a new 52-week high on Friday . The company traded as high as $271.46 and last traded at $270.30, with a volume of 1525 shares. The stock had previously cl
Mesa Laboratories, Inc. (NASDAQ:MLAB) Director John Bradley Schmieder sold 1,800 shares of the stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $266.46, fo
California Public Employees Retirement System trimmed its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 11.0% during the fourth quarter, according to its most recent disclosure with t

Mesa Laboratories Earns RS Rating Upgrade

12:00am, Wednesday, 19'th Feb 2020
New York, Feb. 17, 2020 -- Reportlinker.com announces the release of the report "Sterilization Monitoring Market by End-user, Product, and Geography - Forecast and Analysis.
Some Mesa Laboratories, Inc. (NASDAQ:MLAB) shareholders may be a little concerned to see that the Independent...
SG Americas Securities LLC lowered its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 85.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exc
What is the best way to invest in medical devices? The sector can be intimidating, but for interested investors it's worth looking into.
Royce & Associates LP lifted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 11.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor
TheStreet lowered shares of Mesa Laboratories (NASDAQ:MLAB) from a b- rating to a c rating in a report issued on Monday morning, TheStreetRatingsTable reports. A number of other brokerages have also w
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE